Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Jianhui Nie and Youchun Wang.
Jianhui Nie
Connection Strength
5.903
Youchun Wang
  1. Functional comparison of SARS-CoV-2 with closely related pangolin and bat coronaviruses. Cell Discov. 2021 Apr 06; 7(1):21.
    View in: PubMed
    Score: 0.938
  2. Establishment and validation of a pseudovirus neutralization assay for SARS-CoV-2. Emerg Microbes Infect. 2020 Dec; 9(1):680-686.
    View in: PubMed
    Score: 0.916
  3. Quantification of SARS-CoV-2 neutralizing antibody by a pseudotyped virus-based assay. Nat Protoc. 2020 11; 15(11):3699-3715.
    View in: PubMed
    Score: 0.905
  4. Nipah pseudovirus system enables evaluation of vaccines in vitro and in vivo using non-BSL-4 facilities. Emerg Microbes Infect. 2019; 8(1):272-281.
    View in: PubMed
    Score: 0.802
  5. Three epitope-distinct human antibodies from RenMab mice neutralize SARS-CoV-2 and cooperatively minimize the escape of mutants. Cell Discov. 2021 Jul 20; 7(1):53.
    View in: PubMed
    Score: 0.239
  6. Cellular tropism and antigenicity of mink-derived SARS-CoV-2 variants. Signal Transduct Target Ther. 2021 05 17; 6(1):196.
    View in: PubMed
    Score: 0.236
  7. SARS-CoV-2 501Y.V2 variants lack higher infectivity but do have immune escape. Cell. 2021 04 29; 184(9):2362-2371.e9.
    View in: PubMed
    Score: 0.233
  8. The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity. Cell. 2020 09 03; 182(5):1284-1294.e9.
    View in: PubMed
    Score: 0.223
  9. Antigenic Drift of Influenza A(H7N9) Virus Hemagglutinin. J Infect Dis. 2019 01 01; 219(1):19-25.
    View in: PubMed
    Score: 0.201
  10. Development of in vitro and in vivo neutralization assays based on the pseudotyped H7N9 virus. Sci Rep. 2018 05 31; 8(1):8484.
    View in: PubMed
    Score: 0.193
  11. Development and optimization of a sensitive pseudovirus-based assay for HIV-1 neutralizing antibodies detection using A3R5 cells. Hum Vaccin Immunother. 2018 01 02; 14(1):199-208.
    View in: PubMed
    Score: 0.184
  12. Naturally Occurring Single Amino Acid Substitution in the L1 Major Capsid Protein of Human Papillomavirus Type 16: Alteration of Susceptibility to Antibody-Mediated Neutralization. J Infect Dis. 2017 10 17; 216(7):867-876.
    View in: PubMed
    Score: 0.184
  13. An LASV GPC pseudotyped virus based reporter system enables evaluation of vaccines in mice under non-BSL-4 conditions. Vaccine. 2017 09 12; 35(38):5172-5178.
    View in: PubMed
    Score: 0.182
  14. A bioluminescent imaging mouse model for Marburg virus based on a pseudovirus system. Hum Vaccin Immunother. 2017 08 03; 13(8):1811-1817.
    View in: PubMed
    Score: 0.179
  15. The Antigenicity of Epidemic SARS-CoV-2 Variants in the United Kingdom. Front Immunol. 2021; 12:687869.
    View in: PubMed
    Score: 0.059
  16. The first Chinese national standards for SARS-CoV-2 neutralizing antibody. Vaccine. 2021 06 23; 39(28):3724-3730.
    View in: PubMed
    Score: 0.059
  17. Structurally Resolved SARS-CoV-2 Antibody Shows High Efficacy in Severely Infected Hamsters and Provides a Potent Cocktail Pairing Strategy. Cell. 2020 11 12; 183(4):1013-1023.e13.
    View in: PubMed
    Score: 0.056
  18. A Thermostable mRNA Vaccine against COVID-19. Cell. 2020 09 03; 182(5):1271-1283.e16.
    View in: PubMed
    Score: 0.056
  19. Structural basis for neutralization of SARS-CoV-2 and SARS-CoV by a potent therapeutic antibody. Science. 2020 09 18; 369(6510):1505-1509.
    View in: PubMed
    Score: 0.056
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.